Skip to Content
Søg Menu

FDA Approves Lecanemab for Treatment of Early Alzheimer’s Disease

FDA has given full accelerated approval of lecanemab for treatment of early Alzheimer’s Disease.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Kristian Steen Frederiksen

Nordic Evening EAN 2024: Highlights on Alzheimer’s

/ Kristian Steen Frederiksen
AlzheimerEAN24 Play the Video 4:05
Kristian Steen Frederiksen

New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

/ Kristian Steen Frederiksen
AlzheimerEAN24 Play the Video 4:28
Michael Schöll

Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis

/ Michael Schöll
AlzheimerEAN24 Play the Video 3:15
Sanna-Kaisa Herukka

Anti-Amyloid Antibodies in Alzheimer’s Disease: New Treatments on the Horizon

/ Sanna-Kaisa Herukka
AlzheimerEAN24 Play the Video 1:34
Ludmilla Morozova-Roche

The Role of Pro-Inflammatory S100A9 Protein in Amyloid-Neuroinflammatory Cascade in Neurodegenerative Diseases

/ Ludmilla Morozova-Roche
AlzheimerEAN24Parkinsons Play the Video 4:38
Miia Kivipelto

The Meaningful Benefits for Patients with Alzheimer’s Disease

/ Miia Kivipelto
AlzheimerEAN24 Play the Video 2:34
Lutz Frölich

Alzheimer’s Disease – Clinical Implementation of New Anti-Amyloid Treatment

/ Lutz Frölich
AlzheimerEAN24 Play the Video 02:08
Aftab Bakhtiari

Early Cerebral Amyloid-β Accumulation and Hypermetabolism are Associated with Subtle Cognitive Deficits Before Accelerated Cerebral Atrophy

/ Aftab Bakhtiari
Alzheimer Play the Video 7:28
Henrik Zetterberg

New Biochemical Markers and Anti-Amyloid Antibody Treatments of Alzheimer’s Disease

/ Henrik Zetterberg
Alzheimer Play the Video 08:15

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen
Back to top